AR247728A1 - Procedimiento para separar el isomero activo del cimaterol y procedimiento para preparar las sales diastereoisomeras de dicho isomero - Google Patents

Procedimiento para separar el isomero activo del cimaterol y procedimiento para preparar las sales diastereoisomeras de dicho isomero

Info

Publication number
AR247728A1
AR247728A1 AR91319603A AR31960391A AR247728A1 AR 247728 A1 AR247728 A1 AR 247728A1 AR 91319603 A AR91319603 A AR 91319603A AR 31960391 A AR31960391 A AR 31960391A AR 247728 A1 AR247728 A1 AR 247728A1
Authority
AR
Argentina
Prior art keywords
procedure
isomer
tartarico
separate
cimaterol
Prior art date
Application number
AR91319603A
Other languages
English (en)
Spanish (es)
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Application granted granted Critical
Publication of AR247728A1 publication Critical patent/AR247728A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/59—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Birds (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AR91319603A 1990-05-04 1991-05-03 Procedimiento para separar el isomero activo del cimaterol y procedimiento para preparar las sales diastereoisomeras de dicho isomero AR247728A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4014252A DE4014252A1 (de) 1990-05-04 1990-05-04 Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Publications (1)

Publication Number Publication Date
AR247728A1 true AR247728A1 (es) 1995-03-31

Family

ID=6405664

Family Applications (1)

Application Number Title Priority Date Filing Date
AR91319603A AR247728A1 (es) 1990-05-04 1991-05-03 Procedimiento para separar el isomero activo del cimaterol y procedimiento para preparar las sales diastereoisomeras de dicho isomero

Country Status (27)

Country Link
US (4) US5248695A (OSRAM)
EP (2) EP0589488B1 (OSRAM)
JP (1) JP2944777B2 (OSRAM)
KR (1) KR0183024B1 (OSRAM)
AR (1) AR247728A1 (OSRAM)
AT (2) ATE158277T1 (OSRAM)
AU (1) AU645313B2 (OSRAM)
BG (1) BG60743B1 (OSRAM)
CA (1) CA2041818C (OSRAM)
CZ (1) CZ286389B6 (OSRAM)
DE (3) DE4014252A1 (OSRAM)
DK (2) DK0455155T3 (OSRAM)
ES (2) ES2075255T3 (OSRAM)
FI (1) FI109600B (OSRAM)
GR (2) GR3017064T3 (OSRAM)
HU (1) HU214335B (OSRAM)
ID (1) ID966B (OSRAM)
IE (2) IE80651B1 (OSRAM)
IL (1) IL98030A (OSRAM)
NO (1) NO174803B (OSRAM)
NZ (1) NZ238032A (OSRAM)
PT (1) PT97544B (OSRAM)
RU (1) RU2002737C1 (OSRAM)
SG (1) SG45439A1 (OSRAM)
SK (1) SK279258B6 (OSRAM)
TW (1) TW197415B (OSRAM)
ZA (1) ZA913337B (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer
GB9107196D0 (en) * 1991-04-05 1991-05-22 Sandoz Ag Improvements in or relating to organic compounds
GB2289842B (en) * 1991-04-05 1996-01-31 Sepracor Inc Improved use of ß2 bronchodilator drugs
EP0892639A4 (en) * 1996-01-29 1999-06-09 Savor Evelyn PROCESS FOR THE TREATMENT OF UNWANTED UTERINE CONTRACTIONS USING OPTICALLY PURE R OR RR ISOMERS OF AGONIST -g (b) -2 ADRENERGIC AGONISTS
EP1787529A3 (en) * 1997-04-30 2009-11-18 Courage Corporation Pty Ltd. Composition and methods using an eutomer
BR9815470A (pt) 1997-04-30 2001-10-23 Bridge Pharma Inc Composição e processo usando um eutÈmero
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
RU2201420C2 (ru) * 1998-11-03 2003-03-27 Новартис Аг Нитрилы дипептидов
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
EE200200602A (et) * 2000-04-27 2004-04-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pikatoimelised beetamimeetikumid, meetod nende valmistamiseks ja nende kasutamine ravimitena
US20030162459A1 (en) * 2002-02-27 2003-08-28 Osbon Robert Lindsay Method for producing a nonwoven fabric with enhanced characteristics
WO2004103057A2 (en) * 2003-05-15 2004-12-02 The University Of Georgia Research Foundation, Inc. Compositions and methods for inducing adipose tissue cell death
US20070027076A1 (en) 2003-09-09 2007-02-01 Fumapham Ag Use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
SG124283A1 (en) * 2004-03-24 2006-08-30 Trusted Hub Ltd Document signature method & system
DE602006015387D1 (de) * 2005-04-13 2010-08-26 Astion Dev As Beta-2 Adrenoceptor Agonisten zur Behandlung von Bindegewebserkrankungen der Haut
US20090181369A1 (en) * 2005-05-27 2009-07-16 George Q Daley Methods for the Treatment of Disease
US20090305225A1 (en) * 2005-06-13 2009-12-10 Galbraith Richard A Inhibition of Creatine Uptake to Promote Weight Loss
RU2408014C2 (ru) * 2009-03-10 2010-12-27 Государственное образовательное учреждение высшего профессионального образования "Российский государственный медицинский университет им. Н.И. Пирогова Министерства здравоохранения и социального развития Российской Федерации" Способ прогнозирования преждевременных родов инфекционного генеза
EP2925725B1 (en) 2012-12-03 2016-11-09 Pfizer Inc. Novel selective androgen receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL136601C (OSRAM) * 1967-06-15
US4119710A (en) * 1972-12-18 1978-10-10 Boehringer Ingelheim Gmbh Bronchospasmolytic 1-(p-amino-phenyl)-2-amino-ethanols-(1) and salts
US4407819A (en) * 1980-08-25 1983-10-04 American Cyanamid Company Phenylethanolamine derivatives and acid addition salts thereof for the depression of fat deposition in warm blooded animals
US4814350A (en) * 1986-09-10 1989-03-21 American Cyanamid Company Method of treating diabetes with 5-[1-hydroxy-2-(isopropylamino)ethyl]anthranilonitrile
US4792546A (en) * 1986-12-05 1988-12-20 American Cyanamid Company Method for increasing weight gains and reducing deposition of fat in animals
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Also Published As

Publication number Publication date
EP0455155A1 (de) 1991-11-06
IL98030A0 (en) 1992-06-21
JP2944777B2 (ja) 1999-09-06
KR910019966A (ko) 1991-12-19
ES2075255T3 (es) 1995-10-01
IE80651B1 (en) 1998-11-04
NZ238032A (en) 1996-02-27
US5395957A (en) 1995-03-07
CZ286389B6 (cs) 2000-03-15
BG94342A (en) 1994-06-30
SG45439A1 (en) 1998-01-16
ID966B (id) 1996-09-30
AU7611191A (en) 1991-11-07
DE59105957D1 (de) 1995-08-17
EP0455155B1 (de) 1995-07-12
RU2002737C1 (ru) 1993-11-15
FI912151L (fi) 1991-11-05
ATE124932T1 (de) 1995-07-15
GR3017064T3 (en) 1995-11-30
IL98030A (en) 1995-12-31
NO174803C (OSRAM) 1994-07-13
GR3025547T3 (en) 1998-03-31
CA2041818C (en) 2003-02-11
DK0455155T3 (da) 1995-11-13
ZA913337B (en) 1993-01-27
US5248695A (en) 1993-09-28
HU214335B (hu) 1998-03-02
US5292753A (en) 1994-03-08
JPH04225944A (ja) 1992-08-14
SK279258B6 (sk) 1998-08-05
PT97544B (pt) 1998-08-31
EP0589488A1 (de) 1994-03-30
FI912151A0 (fi) 1991-05-03
DK0589488T3 (da) 1998-05-04
PT97544A (pt) 1992-01-31
EP0589488B1 (de) 1997-09-17
DE4014252A1 (de) 1991-11-07
US5648386A (en) 1997-07-15
AU645313B2 (en) 1994-01-13
ES2109412T3 (es) 1998-01-16
ATE158277T1 (de) 1997-10-15
BG60743B1 (bg) 1996-02-29
FI109600B (fi) 2002-09-13
NO911746L (no) 1991-11-05
CA2041818A1 (en) 1991-11-05
IE69017B1 (en) 1996-07-24
NO174803B (no) 1994-04-05
DE59108853D1 (de) 1997-10-23
NO911746D0 (no) 1991-05-03
HU911502D0 (en) 1991-11-28
TW197415B (OSRAM) 1993-01-01
IE911507A1 (en) 1991-11-06
KR0183024B1 (ko) 1999-05-15
CS129291A3 (en) 1991-11-12
HUT60999A (en) 1992-11-30

Similar Documents

Publication Publication Date Title
AR247728A1 (es) Procedimiento para separar el isomero activo del cimaterol y procedimiento para preparar las sales diastereoisomeras de dicho isomero
ES2150567T3 (es) Antagonistas del factor de liberacion de la corticotropina.
ES2090217T3 (es) Laca fotosensible.
ES2056105T3 (es) Di-t-butilfenoles sustituidos.
CO4290349A1 (es) Procedimiento para la preparacion de propanamina asimetrica
DK0670825T3 (da) Salpetersyreestere, der har farmakologisk aktivitet, og fremgangsmåde til deres fremstilling
ES467828A1 (es) Un procedimiento para preparar nuevos compuestos de cefem y cefam
MX9207494A (es) 4(5)-amino-1,8-naftiridinas substituidas, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
ES2103895T3 (es) Procedimiento para la produccion de acido graso poliinsaturado de tipo omega 9.
PT97680A (pt) Processo para preparacao de novos compostos sulfonilo e de composicoes farmaceuticas que os contem
DE69232205D1 (de) Haarbehandlungszusammensetzung
ES2111404T3 (es) Andamio transportable.
ATE120180T1 (de) 4,5-dihydroxy und 4,5,8-trihydroxy-9,10-dioxo-2- anthracencarbonsäure-dikohlensäureester und urethane mit therapeutischer wirkung.
ES471639A1 (es) Un metodo de separacion de la 3-(3,4-dibenciloxifenil)serinadiastereoisomerica
BR9004262A (pt) Acrilatos,processo para sua preparacao,composicoes pesticidas,utilizacao,processo para o combate a parasitas e para a preparacao de composicoes,hidroxiacrilatos,processo para sua preparacao,acetatos e processo para sua preparacao
ES8504192A1 (es) Procedimiento para la preparacion de cis yno trans hidroxiiminooctahidroindolo(2,3-a)-quinolizina racemicos (como divisional de la solicitud de patente de invencion num. 513.016, presentada el 11 de junio de 1982)
ES2110000T3 (es) Procedimiento para la obtencion de los senosidos a, b, y a1.
PT100439A (pt) Esteres de arilalquilo do acido 4,5-dihidroxi-9,10-dihidro-9,10-dioxo-2-antracenocarboxilico com actividade terapeutica
MX9307365A (es) Proceso de separacion.
ATE135527T1 (de) Bekämpfung von parasitischen nematoden
ES2042647T3 (es) Procedimiento para la obtencion de acido adipico.
ES2058181T3 (es) Procedimiento para la obtencion de esteres del acido 5-formil-valerico.
ES8504807A1 (es) Procedimiento para preparar nuevas 4-fenil-tetrahidrofurano (2, 3-c) piridinas
ES2184150T3 (es) Uso de derivados de los acidos 7-(1-aminometil-2-oxa-7-aza-biciclo(3.3.0)oct-7il)-quinoloncarboxilico y -naftiridoncarboxilico para el tratamiento de infecciones causadas por helicobacter pylori y de las afecciones gastroduodenales asociadas con ellas.
ES2177103T3 (es) Terapia de combinacion para el tratamiento del sida.